The triple negative breast cancer survival rate is a general point of reference that is sometimes used by physicians when discussing patient outcomes. Like all other cancer survival rates, it must be viewed in context and cannot be used to predict the outlook for any specific patient.
It is understandable, however, that a patient might be interested in learning as much as possible about triple negative breast cancer, including the survival rate, which can sometimes provide a general, but helpful, perspective. The most accurate source of information is a personal consultation with a physician, who can provide individualized information based on the:
- Cancer stage
- Cancer grade
- Patient’s age
- Patient’s overall health
- Patient’s response to treatment
It’s important to remember that no one, not even a physician, can forecast exactly how a certain triple negative breast cancer case will progress or respond to treatment. Survival rates, while sometimes useful as benchmarks, are based on broad national statistics. These statistics are derived from information relating to patients who were diagnosed and treated several years ago, and likely before many current breast cancer treatment options were available. The bottom line is that every breast cancer patient has a unique experience that cannot be accurately predicted.
A nationally recognized leader in cancer research, Moffitt Cancer Center offers the latest advances in treatments as well as robust clinical trials, which help us to achieve overall breast cancer survival rates that exceed national averages. We are committed to providing comprehensive care and compassionate support that enhance each patient’s quality of life.
If you have questions about the triple negative breast cancer survival rate, you don’t need a referral to consult with the outstanding breast cancer team at Moffitt. Just call 1-888-663-3488 or request to schedule an appointment online.